Profoundly lower muscle mass and rate of contractile protein synthesis in boys with Duchenne muscular dystrophy

William J Evans, Mahalakshmi Shankaran, Edward C Smith, Carl Morris, Edna Nyangau, Alec Bizieff, Marcy Matthews, Hussein Mohamed, Marc Hellerstein, William J Evans, Mahalakshmi Shankaran, Edward C Smith, Carl Morris, Edna Nyangau, Alec Bizieff, Marcy Matthews, Hussein Mohamed, Marc Hellerstein

Abstract

Boys with Duchenne muscular dystrophy (DMD) experience a progressive loss of functional muscle mass, with fibrosis and lipid accumulation. Accurate evaluation of whole-body functional muscle mass (MM) in DMD patients has not previously been possible and the rate of synthesis of muscle proteins remains unexplored. We used non-invasive, stable isotope-based methods from plasma and urine to measure the fractional rate of muscle protein synthesis (FSR) functional muscle mass (MM), and fat free mass (FFM) in 10 DMD (6-17 years) and 9 age-matched healthy subjects. An oral dose of D3 creatine in 70% 2 H2 O was administered to determine MM and FFM followed by daily 70% 2 H2 O to measure protein FSR. Functional MM was profoundly reduced in DMD subjects compared to controls (17% vs. 41% of body weight, P < 0.0001), particularly in older, non-ambulant patients in whom functional MM was extraordinarily low (<13% body weight). We explored the urine proteome to measure FSR of skeletal muscle-derived proteins. Titin, myosin light chain and gelsolin FSRs were substantially lower in DMD subjects compared to controls (27%, 11% and 40% of control, respectively, P < 0.0001) and were strongly correlated. There were no differences in muscle-derived sarcoplasmic proteins FSRs (creatine kinase M-type and carbonic anhydrase-3) measured in plasma. These data demonstrate that both functional MM, body composition and muscle protein synthesis rates can be quantified non-invasively and are markedly different between DMD and control subjects and suggest that the rate of contractile but not sarcoplasmic protein synthesis is affected by a lack of dystrophin. KEY POINTS: Duchenne muscular dystrophy (DMD) results in a progressive loss of functional skeletal muscle but total body functional muscle mass or rates of muscle protein synthesis have not previously been assessed in these patients. D3 -creatine dilution was used to measure total functional muscle mass and oral 2 H2 O was used to examine the rates of muscle protein synthesis non-invasively in boys with DMD and healthy controls using urine samples. Muscle mass was profoundly lower in DMD compared to control subjects, particularly in older, non-ambulant patients. The rates of contractile protein synthesis but not sarcoplasmic proteins were substantially lower in DMD. These results may provide non-invasive biomarkers for disease progression and therapeutic efficacy in DMD and other neuromuscular diseases.

Keywords: creatine; creatine kinase M-type; creatinine; muscle protein synthesis; myosin light chain; skeletal muscle; titin.

© 2021 The Authors. The Journal of Physiology © 2021 The Physiological Society.

References

    1. Afkarian M, Bhasin M, Dillon ST, Guerrero MC, Nelson RG, Knowler WC, Thadhani R & Libermann TA (2010). Optimizing a proteomics platform for urine biomarker discovery. Mol Cell Proteomics 9, 2195-2204.
    1. Akima H, Lott D, Senesac C, Deol J, Germain S, Arpan I, Bendixen R, Lee SH, Walter G & Vandenborne K (2012). Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul Disord 22, 16-25.
    1. Barnard AM, Willcocks RJ, Triplett WT, Forbes SC, Daniels MJ, Chakraborty S, Lott DJ, Senesac CR, Finanger EL, Harrington AT, Tennekoon G, Arora H, Wang DJ, Sweeney HL, Rooney WD, Walter GA & Vandenborne K (2020). MR biomarkers predict clinical function in Duchenne muscular dystrophy. Neurology 94, e897-e909.
    1. Boca SM, Nishida M, Harris M, Rao S, Cheema AK, Gill K, Seol H, Morgenroth LP, Henricson E, McDonald C, Mah JK, Clemens PR, Hoffman EP, Hathout Y & Madhavan S (2016). Discovery of metabolic biomarkers for duchenne muscular dystrophy within a natural history study. PLoS One 11, e0153461.
    1. Burch PM, Pogoryelova O, Goldstein R, Bennett D, Guglieri M, Straub V, Bushby K, Lochmuller H & Morris C (2015). Muscle-derived proteins as serum biomarkers for monitoring disease progression in three forms of muscular dystrophy. J Neuromuscul Dis 2, 241-255.
    1. Cawthon PM, Orwoll ES, Peters KE, Ensrud KE, Cauley JA, Kado DM, Stefanick ML, Shikany JM, Strotmeyer ES, Glynn NW, Caserotti P, Shankaran M, Hellerstein M, Cummings SR, Evans WJ & Osteoporotic Fractures in Men Study Research Group (2019). Strong relation between muscle mass determined by D3-creatine dilution, physical performance and incidence of falls and mobility limitations in a prospective cohort of older men. J Gerontol A Biol Sci Med Sci. 74, 844-852.
    1. Cegielski J, Wilkinson DJ, Brook MS, Boereboom C, Phillips BE, Gladman JFR, Smith K & Atherton PJ (2021). Combined in vivo muscle mass, muscle protein synthesis and muscle protein breakdown measurement: a ‘Combined Oral Stable Isotope Assessment of Muscle (COSIAM)’ approach. Geroscience (in press; DOI: 10.1007/s11357-021-00386-2).
    1. Chrzanowski SM, Baligand C, Willcocks RJ, Deol J, Schmalfuss I, Lott DJ, Daniels MJ, Senesac C, Walter GA & Vandenborne K (2017). Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy. Acta Myol 36, 151-162.
    1. Clark RV, Walker AC, O'Connor-Semmes RL, Leonard MS, Miller RR, Stimpson SA, Turner SM, Ravussin E, Cefalu WT, Hellerstein MK & Evans WJ (2014). Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans. J Appl Physiol (1985) 116, 1605-1613.
    1. Decaris ML, Li KW, Emson CL, Gatmaitan M, Liu S, Wang Y, Nyangau E, Colangelo M, Angel TE, Beysen C, Cui J, Hernandez C, Lazaro L, Brenner DA, Turner SM, Hellerstein MK & Loomba R (2017). Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood. Hepatology 65, 78-88.
    1. de Lamirande E (2007). Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin Thromb Hemost 33, 060-068.
    1. Evans WJ, Scottoline B, Imam F, Hellerstein M, Garton K, Czerwieniec G, Nyangau E & Shankaran M (2020). D3-creatine dilution for the noninvasive measurement of skeletal muscle mass in premature infants. Pediatr Res 89, 1508-1514.
    1. Grilo EC, Cunha TA, Costa ADS, Araujo BGM, Lopes M, Maciel BLL, Alves CX, Vermeulen-Serpa KM, Dourado-Junior MET, Leite-Lais L, Brandao-Neto J & Vale SHL (2020). Validity of bioelectrical impedance to estimate fat-free mass in boys with Duchenne muscular dystrophy. PLoS One 15, e0241722.
    1. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH & Kunkel LM (2002). Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A 99, 15000-15005.
    1. Hathout Y, Liang C, Ogundele M, Xu G, Tawalbeh SM, Dang UJ, Hoffman EP, Gordish-Dressman H, Conklin LS, van den Anker JN, Clemens PR, Mah JK, Henricson E & McDonald C (2019). Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy. Sci Rep 9, 12167.
    1. Hathout Y, Seol H, Han MH, Zhang A, Brown KJ & Hoffman EP (2016). Clinical utility of serum biomarkers in Duchenne muscular dystrophy. Clin Proteomics 13, 9.
    1. Hill DK (1962). The location of creatine phosphate in frog's striated muscle. J Physiol 164, 31-50.
    1. Klingler W, Jurkat-Rott K, Lehmann-Horn F & Schleip R (2012). The role of fibrosis in Duchenne muscular dystrophy. Acta Myol 31, 184-195.
    1. Liu GC, Jong YJ, Chiang CH & Jaw TS (1993). Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 186, 475-480.
    1. Lukaski HC & Johnson PE (1985). A simple, inexpensive method of determining total body water using a tracer dose of D2O and infrared absorption of biological fluids. Am J Clin Nutr 41, 363-370.
    1. Martin FC, Hiller M, Spitali P, Oonk S, Dalebout H, Palmblad M, Chaouch A, Guglieri M, Straub V, Lochmuller H, Niks EH, Verschuuren JJ, Aartsma-Rus A, Deelder AM, van der Burgt YE & t Hoen PA (2014). Fibronectin is a serum biomarker for Duchenne muscular dystrophy. Proteomics Clin Appl 8, 269-278.
    1. Mendell JR, Rodino-Klapac LR, Sahenk Z, Roush K, Bird L, Lowes LP, Alfano L, Gomez AM, Lewis S, Kota J, Malik V, Shontz K, Walker CM, Flanigan KM, Corridore M, Kean JR, Allen HD, Shilling C, Melia KR, Sazani P, Saoud JB, Kaye EM & Eteplirsen Study Group (2013). Eteplirsen for the treatment of Duchenne muscular dystrophy. Annals of Neurology 74, 637-647.
    1. Murphy S, Brinkmeier H, Krautwald M, Henry M, Meleady P & Ohlendieck K (2017). Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin. J Muscle Res Cell Motil 38, 251-268.
    1. Ravenscroft G, Zaharieva IT, Bortolotti CA, Lambrughi M, Pignataro M, Borsari M, Sewry CA, Phadke R, Haliloglu G, Ong R, Goullee H, Whyte T, Consortium UK, Manzur A, Talim B, Kaya U, Osborn DPS, Forrest ARR, Laing NG & Muntoni F (2018). Bi-allelic mutations in MYL1 cause a severe congenital myopathy. Hum Mol Genet 27, 4263-4272.
    1. Rennie MJ, Edwards RHT, Millward DJ, Wolman SL, Halliday D & Matthews DE (1982). Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature 296, 165-167.
    1. Robertson AS, Majchrzak MJ, Smith CM, Gagnon RC, Devidze N, Banks GB, Little SC, Nabbie F, Bounous DI, DiPiero J, Jacobsen LK, Bristow LJ, Ahlijanian MK & Stimpson SA (2017). Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents. Neuromuscul Disord 27, 635-645.
    1. Shankaran M, Czerwieniec G, Fessler C, Wong PA, Killion S, Turner SM, Hellerstein MK & Evans WJ (2018). Dilution of oral D3-Creatine to measure creatine pool size and estimate skeletal muscle mass: development of a correction algorithm. J Cachexia Sarcopenia Muscle 9, 540-546.
    1. Shankaran M, King CL, Angel TE, Holmes WE, Li KW, Colangelo M, Price JC, Turner SM, Bell C, Hamilton KL, Miller BF & Hellerstein MK (2016). Circulating protein synthesis rates reveal skeletal muscle proteome dynamics. J Clin Invest 126, 288-302.
    1. Skalsky AJ, Han JJ, Abresch RT, Shin CS & McDonald CM (2009). Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Muscle Nerve 39, 647-651.
    1. Stimpson SA, Leonard MS, Clifton LG, Poole JC, Turner SM, Shearer TW, Remlinger KS, Clark RV, Hellerstein MK & Evans WJ (2013). Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D-creatine dilution method. J Cachexia Sarcopenia Muscle 4, 217-223,
    1. Stimpson SA, Turner SM, Clifton LG, Poole JC, Mohammed HA, Shearer TW, Waitt GM, Hagerty LL, Remlinger KS, Hellerstein MK & Evans WJ (2012). Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats. J Appl Physiol (1985) 112, 1940-1948.
    1. Strandberg K, Ayoglu B, Roos A, Reza M, Niks E, Signorelli M, Fasterius E, Ponten F, Lochmuller H, Domingos J, Ala P, Muntoni F, Aartsma-Rus A, Spitali P, Nilsson P & Szigyarto CA (2020). Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy. J Neuromuscul Dis 7, 231-246.
    1. Tarnopolsky MA & Parise G (1999). Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve 22, 1228-1233.
    1. Wallimann T, Moser H & Eppenberger HM (1983). Isoenzyme-specific localization of M-line bound creatine kinase in myogenic cells. J Muscle Res Cell Motil 4, 429-441.
    1. Willcocks RJ, Triplett WT, Lott DJ, Forbes SC, Batra A, Sweeney HL, Mendell JR, Vandenborne K & Walter GA (2018). Leg muscle MRI in identical twin boys with duchenne muscular dystrophy. Muscle Nerve 58, E1-E3,

Source: PubMed

3
订阅